MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm9041045

Медицинская библиотека · Journal of clinical medicine · 2020

Prediction of Anti-Cancer Drug-Induced Pneumonia in Lung Cancer Patients: Novel High-Resolution Computed Tomography Fibrosis Scoring.

Gyotoku Hiroshi, Yamaguchi Hiroyuki, Ishimoto Hiroshi, Sato Shuntaro, Taniguchi Hirokazu, Senju Hiroaki, Kakugawa Tomoyuki, Nakatomi Katsumi, Sakamoto Noriho, Fukuda Minoru, Obase Yasushi, Soda Hiroshi, Ashizawa Kazuto, Mukae Hiroshi

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND AND

OBJECTIVE

Pre-existing interstitial lung disease (ILD) in lung cancer patients is considered a risk factor for anti-cancer drug-induced pneumonia; however, a method for evaluating ILD, including mild cases, has not yet been established. We aimed to elucidate whether the quantitative high-resolution computed tomography fibrosis score (HFS) is correlated with the risk of anti-cancer drug-induced pneumonia in lung cancer patients, even in those with mild pre-existing ILD.

METHODS

The retrospective single-institute study cohort comprised 214 lung cancer patients who underwent chemotherapy between April 2013 and March 2016. The HFS quantitatively evaluated the grade of pre-existing ILD. We extracted data regarding age, sex, smoking history, and coexisting factors that could affect the incidence of anti-cancer drug-induced pneumonia. Cox proportional hazard models were used to analyze the effects of the HFS and other factors on the risk of anti-cancer drug-induced pneumonia.

RESULTS

Pre-existing ILD was detected in 61 (29%) of 214 patients, while honeycombing and traction bronchiectasis were observed in only 15 (7.0%) and 10 (4.7%) patients, respectively. Anti-cancer drug-induced pneumonia developed in 19 (8.9%) patients. The risk of anti-cancer drug-induced pneumonia increased in proportion to the HFS (hazard ratio, 1.16 per point; 95% confidence interval, 1.09-1.22; p < 0.0001).

CONCLUSIONS

The quantitative HFS was correlated with the risk of developing anti-cancer drug-induced pneumonia in lung cancer patients, even in the absence of honeycombing or traction bronchiectasis. The quantitative HFS may lead to better management of lung cancer patients with pre-existing ILD.

Для цитирования: Gyotoku Hiroshi, Yamaguchi Hiroyuki, Ishimoto Hiroshi, Sato Shuntaro, Taniguchi Hirokazu, Senju Hiroaki, Kakugawa Tomoyuki, Nakatomi Katsumi, Sakamoto Noriho, Fukuda Minoru, Obase Yasushi, Soda Hiroshi, Ashizawa Kazuto, Mukae Hiroshi. Prediction of Anti-Cancer Drug-Induced Pneumonia in Lung Cancer Patients: Novel High-Resolution Computed Tomography Fibrosis Scoring.. Journal of clinical medicine. 2020. DOI: 10.3390/jcm9041045.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.